MainReads
← Details
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI – GINECO study
Florence Joly, Michel Fabbro, Philippe Follana, Justine Lequesne, Jacques Medioni, Anne Lesoin, Jean-Sébastien Frenel, Sophie Abadie-Lacourtoisie, Anne Floquet, Laurence Gladieff, Benoît You, Céline Gavoille, Elsa Kalbacher, Mélanie Briand, Pierre-Emmanuel Brachet, Florence Giffard, Louis-Bastien Weiswald, Pierre-Alexandre Just, Cécile Blanc-Fournier, Alexandra Leconte, Bénédicte Clarisse, Alexandra Leary, Laurent Poulain
/
-
Loading document from repository...
Unable to Display Document
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.